Comprehensive analysis of antibiotic resistance in Enterobacteriaceae from outpatient urine cultures: Implications for empirical therapy.

IF 0.9
Northern clinics of Istanbul Pub Date : 2025-01-31 eCollection Date: 2025-01-01 DOI:10.14744/nci.2024.25564
Hanife Nur Karakoc, Asli Haykir Solay, Tugba Arikan, Oguz Alp Gurbuz, Zubeyde Lale, Irfan Sencan
{"title":"Comprehensive analysis of antibiotic resistance in Enterobacteriaceae from outpatient urine cultures: Implications for empirical therapy.","authors":"Hanife Nur Karakoc, Asli Haykir Solay, Tugba Arikan, Oguz Alp Gurbuz, Zubeyde Lale, Irfan Sencan","doi":"10.14744/nci.2024.25564","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Urinary tract infections (UTIs) are among the most common bacterial infections. The misuse of antibiotics is one of the factors contributing to the global increase in antimicrobial resistance (AMR), making the management of UTIs more challenging. Our study aims to evaluate the causative agents of UTIs and the factors influencing resistance, as well as to identify antibiotics that can be used in the outpatient treatment of patients diagnosed with UTIs.</p><p><strong>Methods: </strong>This retrospective study was conducted by collecting urine sample results between 2015-2023. The culture results of the urine samples and the results of the antibiotic sensitivity tests of the Enterobacteriaceae isolates were analyzed. Antimicrobial susceptibilities of the isolates were defined using the VITEK<sup>®</sup>2 Compact system (bioMérieux, Marcyl'Etoile, France) and PheonixTM (Becton-Dickinson, NJ, USA). All sensitivity statuses were determined according to EUCAST standards. Data analysis was conducted using SPSS software version 23.</p><p><strong>Results: </strong>1842 culture results were included. 71.5% of the included samples were from women, and the average age of the cases was 63±18. The most commonly grown agent in urine cultures is Escherichia coli. The resistance profile of the Enterobacteriaceae to antibacterial agents was examined, and it was found that the highest resistance rates were against ampicillin (77.92%), cefazolin (52.36%), ciprofloxacin (49.5%), and trimethoprim/sulfamethoxazole (45.5%), while the lowest resistance rates were against meropenem (4.9%), amikacin (7.6%), fosfomycin (11.4%), and nitrofurantoin (11.6%). Comparing resistance rates before and after 2019, a significant increase in resistance to amikacin and nitrofurantoin was observed (p≤0.001). It was found that resistance rates were higher in urine samples from male cases.</p><p><strong>Conclusion: </strong>Our study revealed that patients should be carefully evaluated in terms of the necessity of culture requests and patients should be informed about culture requests due to the high rate of non-growth and contamination in urine culture results. The high rates of antimicrobial resistance were detected, and the outpatient treatment options of UTI patients are narrowing which can increase hospital admission rates. Our study is important because it shows that nitrofurantoin and fosfomycin can be included in the outpatient and empirical treatment of UTI patients.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"36-44"},"PeriodicalIF":0.9000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364464/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Northern clinics of Istanbul","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/nci.2024.25564","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Urinary tract infections (UTIs) are among the most common bacterial infections. The misuse of antibiotics is one of the factors contributing to the global increase in antimicrobial resistance (AMR), making the management of UTIs more challenging. Our study aims to evaluate the causative agents of UTIs and the factors influencing resistance, as well as to identify antibiotics that can be used in the outpatient treatment of patients diagnosed with UTIs.

Methods: This retrospective study was conducted by collecting urine sample results between 2015-2023. The culture results of the urine samples and the results of the antibiotic sensitivity tests of the Enterobacteriaceae isolates were analyzed. Antimicrobial susceptibilities of the isolates were defined using the VITEK®2 Compact system (bioMérieux, Marcyl'Etoile, France) and PheonixTM (Becton-Dickinson, NJ, USA). All sensitivity statuses were determined according to EUCAST standards. Data analysis was conducted using SPSS software version 23.

Results: 1842 culture results were included. 71.5% of the included samples were from women, and the average age of the cases was 63±18. The most commonly grown agent in urine cultures is Escherichia coli. The resistance profile of the Enterobacteriaceae to antibacterial agents was examined, and it was found that the highest resistance rates were against ampicillin (77.92%), cefazolin (52.36%), ciprofloxacin (49.5%), and trimethoprim/sulfamethoxazole (45.5%), while the lowest resistance rates were against meropenem (4.9%), amikacin (7.6%), fosfomycin (11.4%), and nitrofurantoin (11.6%). Comparing resistance rates before and after 2019, a significant increase in resistance to amikacin and nitrofurantoin was observed (p≤0.001). It was found that resistance rates were higher in urine samples from male cases.

Conclusion: Our study revealed that patients should be carefully evaluated in terms of the necessity of culture requests and patients should be informed about culture requests due to the high rate of non-growth and contamination in urine culture results. The high rates of antimicrobial resistance were detected, and the outpatient treatment options of UTI patients are narrowing which can increase hospital admission rates. Our study is important because it shows that nitrofurantoin and fosfomycin can be included in the outpatient and empirical treatment of UTI patients.

Abstract Image

门诊患者尿培养肠杆菌科抗生素耐药性的综合分析:对经验性治疗的启示。
目的:尿路感染是最常见的细菌感染之一。抗生素的滥用是导致全球抗菌素耐药性增加的因素之一,使尿路感染的管理更具挑战性。我们的研究旨在评估尿路感染的病原体和影响耐药的因素,并确定可用于诊断为尿路感染的患者门诊治疗的抗生素。方法:回顾性研究收集2015-2023年尿液样本结果。对尿样培养结果和肠杆菌科分离菌药敏试验结果进行分析。采用VITEK®2 Compact系统(biomacrieux, Marcyl'Etoile, France)和phoenix™(Becton-Dickinson, NJ, USA)测定分离株的抗菌药物敏感性。所有灵敏度状态均按EUCAST标准测定。数据分析采用SPSS软件23版。结果:纳入1842例培养结果。71.5%为女性,平均年龄63±18岁。尿培养物中最常见的生长因子是大肠杆菌。结果显示,肠杆菌科细菌对抗菌药物的耐药率最高的是氨苄西林(77.92%)、头孢唑林(52.36%)、环丙沙星(49.5%)和甲氧苄啶/磺胺甲恶唑(45.5%),最低的是美罗培南(4.9%)、阿米卡星(7.6%)、磷霉素(11.4%)和呋喃妥英(11.6%)。对比2019年前后的耐药率,阿米卡星和呋喃妥因耐药率显著升高(p≤0.001)。在男性病例的尿液样本中发现耐药率较高。结论:我们的研究表明,患者应仔细评估培养要求的必要性,并且由于尿培养结果中不生长和污染的高发生率,患者应告知培养要求。抗菌药物耐药率较高,尿路感染患者的门诊治疗选择正在缩小,这可能增加住院率。我们的研究很重要,因为它表明呋喃妥因和磷霉素可以纳入门诊和尿路感染患者的经验治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信